Caveman vs LynxKite

A side-by-side look at pricing, capabilities, pros, cons, and our editorial scores.

	Caveman Agents	LynxKite Agents
Tagline	The token-efficient stack for agent-native development	No-code AI orchestration platform built for graph-native pipelines in drug discovery and enterprise analytics.
Category	Agents	Agents
Pricing	Freemium· Free: $0 · Indie: $29/mo · Team: $349/mo · Enterprise: Custom	Enterprise· Contact sales; no public pricing
Model	Model-agnostic proxy (Claude, GPT, Gemini, 30+ others); ships CaveGemma, a fine-tuned Gemma-4 released under MIT	Multi-model (LLM agents + GNNs + NVIDIA BioNeMo)
Editorial score	—	6.9 / 10
Use cases	LLM cost optimizationMulti-provider AI gatewayPrompt and output compressionCross-model request routingLLM spend observabilityAgent SDK developmentShadow-mode optimization testingEnterprise AI governance and audit	drug-discoverygraph-neural-networksknowledge-graphsai-workflow-orchestrationenterprise-ml-pipelines
Pros	Vendor-neutral: works across Claude, GPT, Gemini and 30+ agent runtimes rather than locking you to one provider Open-source core (MIT-licensed Skill package and CaveGemma weights) lets you audit and self-host the primitives Free single-seat Engine tier is enough to prove the cost savings on a real workload before committing Shadow-mode plus PR-driven Autopilot means optimizations land with measured deltas, not blind swaps Per-member/per-key/per-model spend dashboard gives platform teams the accountability layer most LLM stacks lack Ed25519-signed audit receipts are a genuine differentiator for regulated environments	Graph-native: first-class GNNs and knowledge graphs, not bolted on GPU-accelerated via NVIDIA cuGraph and BioNeMo integrations No-code workflow builder usable by non-engineer domain experts Pre-built pharma pipelines shorten time to first model
Cons	Adds a gateway or SDK dependency in the hot path of every LLM call — an extra failure surface to operate The headline '65% cost cut' is workload-dependent; savings on already-terse prompts or single-model shops will be far smaller Enterprise pricing is not published, so budgeting requires a sales conversation Value is thin for solo builders making a handful of API calls a day — this is infrastructure aimed at scaled traffic Compression and cross-model routing can subtly change model behaviour at the margins; regression testing is on you	No public pricing; enterprise sales cycle required Current 2000:MM version is not open source (older 5.x is) Narrow sweet spot outside pharma, finance, and retail verticals
Website	caveman.so	lynxkite.com

Pick Caveman if

✅ Vendor-neutral: works across Claude, GPT, Gemini and 30+ agent runtimes rather than locking you to one provider
✅ Open-source core (MIT-licensed Skill package and CaveGemma weights) lets you audit and self-host the primitives
✅ Free single-seat Engine tier is enough to prove the cost savings on a real workload before committing
✅ Shadow-mode plus PR-driven Autopilot means optimizations land with measured deltas, not blind swaps

Pick LynxKite if

✅ Graph-native: first-class GNNs and knowledge graphs, not bolted on
✅ GPU-accelerated via NVIDIA cuGraph and BioNeMo integrations
✅ No-code workflow builder usable by non-engineer domain experts
✅ Pre-built pharma pipelines shorten time to first model

Compare a different pair →